BHVN - Biohaven Ltd.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$16.50
DETAILS
HIGH:
$23.00
LOW:
$10.00
MEDIAN:
$16.50
CONSENSUS:
$16.50
UPSIDE:
74.60%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 0.0% |
| EBIT Margin | 0.0% |
| EBITDA Margin | 0.0% |
| Operating Margin | 0.0% |
| Pretax Margin | 0.0% |
| Cont. Ops Margin | 0.0% |
| Net Margin | 0.0% |
| Bottom Line Margin | 0.0% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 3.18 |
| Quick Ratio | 3.18 |
| Solvency Ratio | -1.825 |
| Cash Ratio | 1.98 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-1.64
Peers avg: 28.4
|
| PEG Ratio | 0.06 |
| Forward PEG | 0.06 |
| Price/Book | 23.33 |
| Price/Sales | 0.00 |
| Price/FCF | -1.99 |
| Price/Op Cash Flow | -1.99 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.6177 |
| Debt/Equity | 5.3552 |
| Debt/Capital | 0.8426 |
| Long-Term Debt/Capital | 0.8426 |
| Financial Leverage | 8.67 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.00 |
| Operating Cash Flow Ratio | -5.257 |
| Operating Cash Flow/Sales | 0.0% |
| Free Cash Flow/Operating Cash Flow | 100.1% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | 0.00 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | 0.00 |
| Operating Cash Flow Coverage | -2.19 |
| Capital Expenditure Coverage | -852.36 |
| Dividend + Capital Expenditure Coverage | -852.36 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.00 |
| EPS | -6.865 |
| Debt/Share | 2.5910 |
| Cash/Share | 2.97 |
| Book Value/Share | 0.48 |
| Tangible BV/Share | 0.30 |
| Equity/Share | 0.48 |
| Operating Cash Flow/Share | -5.663 |
| Capital Expenditure/Share | 0.007 |
| FCF/Share | -5.669 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.002 |
| Earnings Before Tax/EBIT | 0.989 |
| Price/Fair Value | 23.33 |
| Debt/Market Cap | 0.2295 |
| Effective Tax Rate | -0.2% |
| Enterprise Value Multiple | -1.74 |